Navigation Links
Eye Drug Macugen Shows Allergic Reactions

The drug Macugen was approved by the Food and Drug Administration (FDA) to treat age-related vision loss known as macular degeneration was reported// to show serious allergic reactions. Pfizer Inc. and OSI Pharmaceuticals said that with use of their eye drug Macugen along with other medications resulted in allergic reactions. FDA says that the companies have already notified the doctors about the reactions, which included allergic swelling around the eyes or lips and other anaphylactic symptoms. After the complaints the companies have added the information about these in their drug's label.

Due to this Pfizer shares closed down 1.6 % at $24.69 on the New York Stock Exchange. Shares of OSI at 3.5 % at $30.02 on the Nasdaq. The companies also warned doctors to evaluate patients for a history of hypersensitivity reactions before giving the drug. The drug makers said that the complaints came in after the injectable drug was approved in the United States in 2004. The sensitivity occurred when Macugen (pegaptanib) was given along with other medications as part of the injection procedure.


'"/>




Page: 1

Related medicine news :

1. Macugen drug for treating degenerative eye disease
2. Experimental treatment for Ebola Virus Shows promising results in mice
3. New Prostate Cancer Vaccine Shows Promise
4. Ebola Treatment Shows Promise
5. New Drug Shows Significant Improvement In HIV-related Heart Condition
6. Greek Study Shows Living In The Hills May Be Healthier
7. Research Shows Carbon Monoxide Prevents Inflammations
8. Latest Research Shows That Multivitamins Might Not Prevent Infections In All Elderly
9. Novartis MS Drug Shows Promising Results
10. MRI Shows Emotional Changes During Menstrual Cycle
11. Bronchiolo-alveolar Carcinoma Shows Sonographic Pattern Of Pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy ... nutraceutical supplements, through its Nova Skin Sciences division, recently announced the launch of ... moisturizer with the power of an anti-aging concentrate. , Anogeissus Leiocarpa ...
(Date:4/28/2017)... NY (PRWEB) , ... April 28, 2017 , ... ... celebrating its 5th anniversary. SearchLight is the premier online modeling resource for fluorescence ... more than 30,000 active users during last 5 years spanning the globe, SearchLight ...
(Date:4/27/2017)... , ... April 27, 2017 , ... ... Insights in Incentives, Rewards, and Recognition: A Nudge Guide," a groundbreaking analysis of ... field. Offering practical takeaways to apply immediately to IRR programs, the report highlights ...
(Date:4/27/2017)... Minneapolis, Minnesota (PRWEB) , ... April 27, 2017 ... ... Smith and her husband Dan Gasby the 2017 Public Leadership in Neurology Award ... Bob Woodruff, retired professional athlete Tedy Bruschi, Vice President Walter Mondale, actor Michael ...
(Date:4/27/2017)... ... 27, 2017 , ... Goodcents Deli Fresh Subs announced a franchise expansion agreement ... year. , The first new location will open at the corner of 27th ... and Northern Lights Drive this fall. And the third location is in the process ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  Cogentix Medical, ... focused on providing the Urology, Uro/Gyn and Gynecology ... that Ash Keswani has joined the Company as ... this newly created position, Mr. Keswani will report ... CEO. "Our organization is delighted that ...
(Date:4/20/2017)... Research and Markets has announced ... Market Prospects: Addressing Production Complexities Through Risk Management and ... ... Pipeline and Market Prospects: Overcoming Production Complexities Through Risk ... of the current trends in the global biosimilars market, ...
(Date:4/20/2017)... 2017  CVS Pharmacy, the retail division of ... store design to enhance the retail customer experience ... products and expanded beauty selections paired with informational ... new offerings. Together with its innovative digital programs, ... customer experience at CVS Pharmacy.  ...
Breaking Medicine Technology: